BELLEVUE, Wash.—Innovega has announced that the U.S. Patent and Trademark Office issued a notice of allowance to complement the company’s 12 patents. A recent patent, “Contact Lens and Method and Systems for Constructing a Contact Lens,” claims the ability to supply the required oxygen to the cornea when the lens contains components that are not oxygen permeable. Innovega has patented systems and methods for coupling eyeborne optics with display eyewear. The company claims two goals with these patents: removing the need for heavy, cumbersome eyewear and giving users a panoramic field of view.

The company’s most recent patent is an add-on to one they were given in 2018. Both were filed by inventors and scientists Jerome Legerton, William Meyers and Jay Marsh.

Steve Willey, Innovega co-founder, president and CEO, said, “Our team continues to advance our intellectual property, refine our display eyewear reference designs, sponsor clinical testing and conduct discussions about our technology with potential contact lens and display eyewear partners.” In addition to these new patents, Innovega is in the midst of conducting its phase III FDA clinical investigations for the iOptik and eMacula contact lenses.